Cargando…

Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis

Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer related to asbestos exposure. The discovery of soluble biomarkers with diagnostic/prognostic and/or therapeutic properties would improve therapeutic care of MPM patients. Currently, soluble biomarkers described present weaknesses p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smeele, Patrick, d’Almeida, Sènan Mickaël, Meiller, Clément, Chéné, Anne-Laure, Liddell, Charly, Cellerin, Laurent, Montagne, François, Deshayes, Sophie, Benziane, Sarah, Copin, Marie-Christine, Hofman, Paul, Le Pimpec-Barthes, Françoise, Porte, Henri, Scherpereel, Arnaud, Grégoire, Marc, Jean, Didier, Blanquart, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180566/ https://www.ncbi.nlm.nih.gov/pubmed/30309369 http://dx.doi.org/10.1186/s12943-018-0891-0

Ejemplares similares

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
por: Blondy, Thibaut, et al.
Publicado: (2020)

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
por: Quetel, Lisa, et al.
Publicado: (2020)

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
por: Blum, Yuna, et al.
Publicado: (2019)

Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma
por: Denis, Iza, et al.
Publicado: (2014)

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
por: Meiller, Clément, et al.
Publicado: (2021)

Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
por: Bensaid, Douae, et al.
Publicado: (2018)

IL‐7 is expressed in malignant mesothelioma and has a prognostic value
por: Mai, Hoa‐Le, et al.
Publicado: (2022)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Oncolytic virotherapy for human malignant mesothelioma: recent advances
por: Boisgerault, Nicolas, et al.
Publicado: (2015)

Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy
por: Porta, Chiara, et al.
Publicado: (2023)

Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma
por: Nader, Joëlle S., et al.
Publicado: (2018)

Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine
por: Roulois, David, et al.
Publicado: (2016)

KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021)

The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition
por: Felley-Bosco, Emanuela, et al.
Publicado: (2023)

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
por: Achard, Carole, et al.
Publicado: (2015)

Defect in recruiting effector memory CD8(+) T-cells in malignant pleural effusions compared to normal pleural fluid
por: Scherpereel, Arnaud, et al.
Publicado: (2013)

Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells
por: Pimpec-Barthes, F Le, et al.
Publicado: (1999)

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
por: Blanquart, Christophe, et al.
Publicado: (2020)

Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma
por: Sun, Suna, et al.
Publicado: (2022)

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions
por: Alcala, Nicolas, et al.
Publicado: (2019)

Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis
por: Chouaid, Christos, et al.
Publicado: (2018)

Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma
por: Willems, Mégane, et al.
Publicado: (2023)

Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics
por: Stern, Esther, et al.
Publicado: (2023)

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
por: Treasure, Tom, et al.
Publicado: (2011)

Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
por: Hariharan, Ananya, et al.
Publicado: (2022)

Brain-derived neurotrophic factor in primary headaches
por: Fischer, Marlene, et al.
Publicado: (2012)

Challenge of a therapeutic sequence: rare case of heart failure in mitral valvular disease intensified by an extreme mediastinal shift from major diaphragmatic eventration
por: Le Pimpec-Barthes, Françoise, et al.
Publicado: (2022)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study
por: Assié, Jean-Baptiste, et al.
Publicado: (2022)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Pleural Mesothelioma in the Era of Immunotherapy
por: Chevallier, Mathieu, et al.
Publicado: (2023)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

Post-traumatic massive hand lymphedema fully cured by vascularized lymph node flap transfer
por: Becker, Corinne, et al.
Publicado: (2018)

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
por: Mangiante, Lise, et al.
Publicado: (2023)

Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients
por: Raiko, Irina, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ej5k502a93r7qjugaeh651li1k